Ani Biotech develops and manufactures rapid immunodiagnostic tests by utilizing 3 different techniques: dry-dot agglutination, one-step and two-step techniques. Technological orientation is a key word in Ani Biotech.

The main application areas are fertility hormones, bacterial and viral antigens and antibodies based rapid diagnostic tests. The latest products include a patented celiac disease test, myeloperoxydase and high sensitive CRP quantitative tests for cardiac infarct prediction and novel Parvo B19 test, all utilizing whole blood finger tip samples.

Ani Biotech products are marketed and distributed by specialized diagnostic and pharmaceutical companies worldwide. The largest customers are based in Europe and Asia. The tests are CE marked and several tests are also FDA approved.